SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000919574-22-006999
Filing Date
2022-12-07
Accepted
2022-12-07 13:51:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9882032_13d-a.htm SC 13D/A 115704
  Complete submission text file 0000919574-22-006999.txt   117262
Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019
Business Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 212.300.5575
Casdin Capital, LLC (Filed by) CIK: 0001534261 (see all company filings)

IRS No.: 800752351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Subject) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92757 | Film No.: 221449909
SIC: 2836 Biological Products, (No Diagnostic Substances)